More Evidence Daily Aspirin May Fight Colon Cancer, Other Gastro Tumors

More Evidence Daily Aspirin May Fight Colon Cancer, Other Gastro Tumors

/ Category: Latest Announcements & News


“Medical research is focusing more and more on personalized medicine, but many personalized treatments are expensive and only useful in small populations,” Frouws said. “We believe that our research shows quite the opposite — it demonstrates the considerable benefit of a cheap, well-established and easily obtainable drug in a larger group of patients, while still targeting the treatment to a specific individual.”


Just how might aspirin help keep these cancers at bay? Frouws’ team believe the drug may boost the immune system’s ability to detect and destroy circulating tumor cells in the blood.


According to the researchers, people who took daily low-dose aspirin after their diagnosis were twice as likely to survive as those who did not. This benefit of taking aspirin was seen after the researchers adjusted for other factors such as sex, age, cancer state, type of treatment, and other health conditions.


In the new study, Frouws’ team looked at outcomes for more than 13,700 patients diagnosed with a gastrointestinal cancer between 1998 and 2011. Patients were tracked for an average of more than four years.


He also noted that earlier this year, the influential U.S. Preventive Services Task Force “suggested that certain populations at average risk of colon cancer may benefit from taking low-dose aspirin.”


“For many years, gastroenterologists and oncologists have known that aspirin can improve survival in certain types of hereditary colon cancer,” said Dr. Arun Swaminath, director of the inflammatory bowel disease program at Lenox Hill Hospital in New York City.


“Given that aspirin is a cheap, off-patent drug with relatively few side effects, this will have a great impact on health care systems as well as patients,” study lead author Dr. Martine Frouws, of Leiden University Medical Center in the Netherlands, said in a news release from the European Cancer Congress (ECC).


MONDAY, Sept. 28, 2015 (HealthDay News) — Millions of Americans already take a low-dose daily aspirin to help shield their hearts. Now, a new study suggests the same inexpensive pill might extend survival for patients battling cancers of the gastrointestinal tract — including tumors of the colon and esophagus.


Talk to health experts and other people like you in WebMD’s Communities. It’s a safe forum where you can create or participate in support groups and discussions about health topics that interest you.


Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.






























Like this post? Get updates via email.

Leave a Reply

© 2020 Primary Care Services, Blount. All Rights Reserved.